Who
Bakker Juliet Tammenoms
Director
Company insider
Files Form 4 as: Director, RxSight; Director, CeriBell; 10% owner, Vera Therapeutics; 10% owner, Sierra Oncology; Director and 10% owner, Eargo; Director and 10% owner, Axonics Modulation Technologies; 10% owner, Inozyme Pharma; Director and 10% owner, Venus Concept.
In numbers
- Trades disclosed
- 105
- Buys
- 15
- Sells
- 15
- Bought
- $59.5M
- Sold
- $50.2M
- Companies
- 12
- Companies where not an officer
- 12
- First trade
- 6 Feb 2009
- Last trade
- 17 Jun 2026
- Last filed
- 18 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 17 Jun 2026filed 18 Jun 2026 | RXST RxSightMedical Devices | SEC FORM 4 Code A | —37,037 | filing |
| 17 Jun 2026filed 18 Jun 2026 | RXST RxSightMedical Devices | SEC FORM 4 Code A | —37,037 | filing |
| 2 Jun 2026filed 4 Jun 2026 | CBLL CeriBellMedical Devices | SEC FORM 4 Code A | —7,838 at $0.00 | filing |
| 2 Jun 2026filed 4 Jun 2026 | CBLL CeriBellMedical Devices | SEC FORM 4 Code A | —7,838 at $0.00 | filing |
| 10 Jun 2025filed 17 Jun 2025 | CBLL CeriBellMedical Devices | SEC FORM 4 Code A | —8,828 at $0.00 | filing |
| 3 Jun 2025filed 4 Jun 2025 | RXST RxSightMedical Devices | SEC FORM 4 Code A | —10,752 | filing |
| 15 Oct 2024filed 16 Oct 2024 | CBLL CeriBelloption or derivative · Medical Devices | SEC FORM 4 Code C | —2,140,600 at $0.00 | filing |
| 15 Oct 2024filed 16 Oct 2024 | CBLL CeriBellMedical Devices | SEC FORM 4 Code C | —2,140,600 | filing |
| 15 Oct 2024filed 16 Oct 2024 | CBLL CeriBellMedical Devices | SEC FORM 4 Bought | $4.0M237,234 at $17.00 | filing |
| 11 Oct 2024filed 16 Oct 2024 | CBLL CeriBellMedical Devices | SEC FORM 4 Code A | —6,618 at $0.00 | filing |
| 6 Jun 2024filed 10 Jun 2024 | RXST RxSightMedical Devices | SEC FORM 4 Code A | —2,554 | filing |
| 17 May 2024filed 21 May 2024 | RXST RxSightMedical Devices | SEC FORM 4 Bought | $305K5,000 at $61.09 | filing |
| 14 Feb 2024filed 15 Feb 2024 | RXST RxSightMedical Devices | SEC FORM 4 Bought | $205K4,000 at $51.29 | filing |
| 12 Feb 2024filed 15 Feb 2024 | RXST RxSightMedical Devices | SEC FORM 4 Bought | $202K4,000 at $50.38 | filing |
| 30 Nov 2023filed 30 Nov 2023 | RXST RxSightMedical Devices | SEC FORM 4 Code J | —445,400 at $0.00 | filing |
| 30 Nov 2023filed 30 Nov 2023 | RXST RxSightMedical Devices | SEC FORM 4 Code J | —693 at $0.00 | filing |
| 30 Nov 2023filed 30 Nov 2023 | RXST RxSightMedical Devices | SEC FORM 4 Code J | —1,617 at $0.00 | filing |
| 29 Nov 2023filed 30 Nov 2023 | RXST RxSightMedical Devices | SEC FORM 4 Sold | $10.4M349,245 at $29.77 | filing |
| 28 Nov 2023filed 30 Nov 2023 | RXST RxSightMedical Devices | SEC FORM 4 Sold | $4.3M145,068 at $29.62 | filing |
| 15 Nov 2023filed 16 Nov 2023 | RXST RxSightMedical Devices | SEC FORM 4 Sold | $10.9M400,000 at $27.20 | filing |
News
RxSight Appoints Eye Care Industry Leaders to Drive Commercial TransformationRXST · manilatimes.net · 19 Oct 2026RxSight (NASDAQ:RXST) vs. Coloplast A/S (OTCMKTS:CLPBY) Head to Head AnalysisRXST · tickerreport.com · 14 Oct 2026Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Stock Has Consensus Price Target of $48.71COLL · dailypolitical.com · 13 Oct 2026Financial Survey: RxSight (NASDAQ:RXST) versus Envoy Medical (NASDAQ:COCH)RXST · themarketsdaily.com · 11 Oct 2026Insider Selling: Corcept Therapeutics (NASDAQ:CORT) Insider Sells $93,474.00 in StockCORT · tickerreport.com · 8 Oct 2026Comparing Corcept Therapeutics (NASDAQ:CORT) & Xeris Biopharma (NASDAQ:XERS)CORT · dailypolitical.com · 7 Oct 2026Comparing Becton, Dickinson and Company (NYSE:BDX) & CeriBell (NASDAQ:CBLL)CBLL · dailypolitical.com · 6 Oct 2026
0 headlines in the last 90 days name Bakker Juliet Tammenoms; 7 articles from the last 14 days about the 5 companies they traded most, at most three about any one of them.